Skip to content

Study · Not a test of the peptide alone · 2026

1 result

Hypoglycaemic coma induced by a falsified semaglutide product: a case report.

Antonacci G, Bortignon E, Bolognesi M, Piano SS, Cadore A, Camuffo L, Venturini F, Faoro S, Favretto D, Romano A, Mengato D

European journal of hospital pharmacy : science and practice19 Aug 2026

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Semaglutide.

  1. 01HumanNot a test of Semaglutide aloneCase report or seriesSafety outcome

    In a 31-year-old woman, a vial sold online as semaglutide contained insulin instead of semaglutide and she was admitted in a hypoglycaemic coma.

    In plain wordsA woman injected a vial sold online as semaglutide. It held insulin, not semaglutide, and she fell into a low blood sugar coma.

    Outcome
    Not applicableContent of falsified semaglutide product and hypoglycaemic coma
    Study

    n = 1

    Outcome group
    Adverse events · Metabolic and weight

    Source sentences

    Summary
    We present a case of a 31-year-old woman who was admitted to the emergency room in a hypoglycaemic coma after self-administrating semaglutide (Ozempic) obtained from a website.
    1 context sentence
    Summary · context
    Toxicological analysis showed that the vial contained insulin instead of semaglutide, therefore leading to severe hypoglycaemia.

    In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semaglutide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.